These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


265 related items for PubMed ID: 32271235

  • 1. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
    Chen T, Sun JL, Zhang J.
    Coron Artery Dis; 2020 Nov; 31(7):586-589. PubMed ID: 32271235
    [Abstract] [Full Text] [Related]

  • 2. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K, Li YJ, Gao S.
    Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
    [Abstract] [Full Text] [Related]

  • 3. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP, Xu WT, Wang L, Li H, Shao CL, Gu HB, Chan SP, Xu HF, Yang XJ.
    Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relationship between uric acid to albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
    Liu W, Ding K, Bao J, Hu Y, Gui Y, Ye L, Wang L.
    Coron Artery Dis; 2023 Dec 01; 34(8):589-594. PubMed ID: 37855441
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
    Zeng M, Yan X, Wu W.
    BMC Cardiovasc Disord; 2021 Sep 17; 21(1):446. PubMed ID: 34535088
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Remnant Lipoprotein Cholesterol Independently Associates With In-Stent Restenosis After Drug-Eluting Stenting for Coronary Artery Disease.
    Xu X, Pandit RU, Han L, Li Y, Guo X.
    Angiology; 2019 Oct 17; 70(9):853-859. PubMed ID: 31167539
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis.
    Tesche C, De Cecco CN, Vliegenthart R, Duguay TM, Stubenrauch AC, Rosenberg RD, Varga-Szemes A, Bayer RR, Yang J, Ebersberger U, Baquet M, Jochheim D, Hoffmann E, Steinberg DH, Chiaramida SA, Schoepf UJ.
    J Cardiovasc Comput Tomogr; 2016 Oct 17; 10(5):377-83. PubMed ID: 27431607
    [Abstract] [Full Text] [Related]

  • 12. Resistant in-stent restenosis in the drug eluting stent era.
    Theodoropoulos K, Mennuni MG, Dangas GD, Meelu OA, Bansilal S, Baber U, Sartori S, Kovacic JC, Moreno PR, Sharma SK, Mehran R, Kini AS.
    Catheter Cardiovasc Interv; 2016 Nov 17; 88(5):777-785. PubMed ID: 27184223
    [Abstract] [Full Text] [Related]

  • 13. Impact of coronary collateral circulation on angiographic in-stent restenosis in patients with stable coronary artery disease and chronic total occlusion.
    Yang ZK, Shen Y, Hu J, Zhang Q, Ding FH, Zhang RY, Lu L, Shen WF.
    Int J Cardiol; 2017 Jan 15; 227():485-489. PubMed ID: 27836292
    [Abstract] [Full Text] [Related]

  • 14. Association of increased serum CTRP5 levels with in-stent restenosis after coronary drug-eluting stent implantation: CTRP5 promoting inflammation, migration and proliferation in vascular smooth muscle cells.
    Shen Y, Li C, Zhang RY, Zhang Q, Shen WF, Ding FH, Lu L.
    Int J Cardiol; 2017 Feb 01; 228():129-136. PubMed ID: 27863353
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.
    Song HG, Kang SJ, Ahn JM, Kim WJ, Lee JY, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Park SJ.
    Catheter Cardiovasc Interv; 2014 May 01; 83(6):873-8. PubMed ID: 22815193
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis.
    Arikawa R, Yamaguchi H, Takaoka J, Miyamura A, Atsuchi N, Ninomiya T, Atsuchi Y, Ohishi M, Terashima M, Kaneda H.
    Cardiovasc Revasc Med; 2015 May 01; 16(1):27-31. PubMed ID: 25578507
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
    Alfonso F, Pérez-Vizcayno MJ, García Del Blanco B, García-Touchard A, López-Mínguez JR, Masotti M, Zueco J, Melgares R, Mainar V, Moreno R, Domínguez A, Sanchís J, Bethencourt A, Moreu J, Cequier A, Martí V, Otaegui I, Bastante T, Gonzalo N, Jiménez-Quevedo P, Cárdenas A, Fernández C, under the auspices of the Interventional Cardiology Working Group of the Spanish Society of Cardiology.
    Circ Cardiovasc Interv; 2016 Jul 01; 9(7):. PubMed ID: 27412868
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.